Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2002 Jun;61(6):499–504. doi: 10.1136/ard.61.6.499

Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors

H Visser 1, K Vos 1, E Zanelli 1, W Verduyn 1, G Schreuder 1, I Speyer 1, F Breedveld 1, J Hazes 1
PMCID: PMC1754119  PMID: 12006321

Abstract

Objectives: (a) To describe the clinical characteristics of acute sarcoid arthritis and the diagnostic value of its presenting clinical features; (b) to evaluate whether disease onset is seasonal; and (c) to evaluate whether smoking behaviour or the presence of HLA class II alleles is a risk factor for the disease.

Methods: 579 consecutive patients with recent onset arthritis who had been newly referred to a rheumatology outpatient clinic were included in a prospective cohort study. The presenting clinical features, the smoking behaviour, and the results of HLA-DQ and HLA-DR DNA typing of 55 patients with sarcoid arthritis, 524 patients with other arthritides of recent onset, and samples of the normal population were compared.

Results: In all cases the disease showed a self limiting arthritis and overall good prognosis. The diagnostic ability of a combination of four clinical features—symmetrical ankle arthritis, symptoms of less than two months, age below 40 years, and erythema nodosum—was exceptionally high. When test positivity is defined as the presence of at least three of four criteria the set rendered a sensitivity of 93%, a specificity of 99%, a positive predictive value of 75%, and a negative predictive value of 99.7%. The disease clustered in the months March–July. The disease was negatively associated with smoking (odds ratio (OR) 0.09; 95% confidence interval (95% CI) 0.02 to 0.37) and positively associated with the presence of the DQ2 (DQB1*0201)-DR3 (DRB1*0301) haplotype (OR 12.33; 95% CI 5.97 to 25.48).

Conclusion: The disease entity acute sarcoid arthritis has highly diagnostic clinical features. The seasonal clustering, the protective effect of smoking, and the association with specific HLA class II antigens support the hypothesis that it results from exposure of susceptible hosts to environmental agents through the lungs.

Full Text

The Full Text of this article is available as a PDF (117.4 KB).

Figure 1 .

Figure 1

Open in a new tab

Distribution of disease onset over the months of the year for patients with sarcoid arthritis (n=55) and with other forms of arthritis (n=524). The monthly proportion of disease onset without influence of seasonality would be 8.3% (dividing 100% by 12).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUCK A. A. Epidemiologic investigations of sarcoidosis. IV. Discussion and summary. Am J Hyg. 1961 Sep;74:189–202. doi: 10.1093/oxfordjournals.aje.a120210. [DOI] [PubMed] [Google Scholar]
  2. Bardinas F., Morera J., Fité E., Plasencia A. Seasonal clustering of sarcoidosis. Lancet. 1989 Aug 19;2(8660):455–456. doi: 10.1016/s0140-6736(89)90638-7. [DOI] [PubMed] [Google Scholar]
  3. Bresnitz E. A., Stolley P. D., Israel H. L., Soper K. Possible risk factors for sarcoidosis. A case-control study. Ann N Y Acad Sci. 1986;465:632–642. doi: 10.1111/j.1749-6632.1986.tb18540.x. [DOI] [PubMed] [Google Scholar]
  4. Brewerton D. A., Cockburn C., James D. C., James D. G., Neville E. HLA antigens in sarcoidosis. Clin Exp Immunol. 1977 Feb;27(2):227–229. [PMC free article] [PubMed] [Google Scholar]
  5. Caplan H. I., Katz W. A., Rubenstein M. Periarticular inflammation, bilateral hilar adenopathy and a sarcoid reaction. Arthritis Rheum. 1970 Mar-Apr;13(2):101–111. doi: 10.1002/art.1780130201. [DOI] [PubMed] [Google Scholar]
  6. DeRemee R. A. The roentgenographic staging of sarcoidosis. Historic and contemporary perspectives. Chest. 1983 Jan;83(1):128–133. doi: 10.1378/chest.83.1.128. [DOI] [PubMed] [Google Scholar]
  7. Douglas A. S., Strachan D. P., Maxwell J. D. Seasonality of tuberculosis: the reverse of other respiratory diseases in the UK. Thorax. 1996 Sep;51(9):944–946. doi: 10.1136/thx.51.9.944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Douglas J. G., Middleton W. G., Gaddie J., Petrie G. R., Choo-Kang Y. F., Prescott R. J., Crompton G. K. Sarcoidosis: a disorder commoner in non-smokers? Thorax. 1986 Oct;41(10):787–791. doi: 10.1136/thx.41.10.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gardner J., Kennedy H. G., Hamblin A., Jones E. HLA associations in sarcoidosis: a study of two ethnic groups. Thorax. 1984 Jan;39(1):19–22. doi: 10.1136/thx.39.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Glennås A., Kvien T. K., Melby K., Refvem O. K., Andrup O., Karstensen B., Thoen J. E. Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol. 1995 Jan;34(1):45–50. doi: 10.1093/rheumatology/34.1.45. [DOI] [PubMed] [Google Scholar]
  11. Gran J. T., Bøhmer E. Acute sarcoid arthritis: a favourable outcome? A retrospective survey of 49 patients with review of the literature. Scand J Rheumatol. 1996;25(2):70–73. doi: 10.3109/03009749609069210. [DOI] [PubMed] [Google Scholar]
  12. Gruchow H. W., Hoffmann R. G., Marx J. J., Jr, Emanuel D. A., Rimm A. A. Precipitating antibodies to farmer's lung antigens in a Wisconsin farming population. Am Rev Respir Dis. 1981 Oct;124(4):411–415. doi: 10.1164/arrd.1981.124.4.411. [DOI] [PubMed] [Google Scholar]
  13. Gumpel J. M., Johns C. J., Shulman L. E. The joint disease of sarcoidosis. Ann Rheum Dis. 1967 May;26(3):194–205. doi: 10.1136/ard.26.3.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hance A. J., Basset F., Saumon G., Danel C., Valeyre D., Battesti J. P., Chrétien J., Georges R. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci. 1986;465:643–656. doi: 10.1111/j.1749-6632.1986.tb18541.x. [DOI] [PubMed] [Google Scholar]
  15. Harf R. A., Ethevenaux C., Gleize J., Perrin-Fayolle M., Guerin J. C., Ollagnier C. Reduced prevalence of smokers in sarcoidosis. Results of a case-control study. Ann N Y Acad Sci. 1986;465:625–631. doi: 10.1111/j.1749-6632.1986.tb18539.x. [DOI] [PubMed] [Google Scholar]
  16. Hedfors E., Lindström F. HLA-B8/DR3 in sarcoidosis. Correlation to acute onset disease with arthritis. Tissue Antigens. 1983 Sep;22(3):200–203. doi: 10.1111/j.1399-0039.1983.tb01192.x. [DOI] [PubMed] [Google Scholar]
  17. Henke C. E., Henke G., Elveback L. R., Beard C. M., Ballard D. J., Kurland L. T. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol. 1986 May;123(5):840–845. doi: 10.1093/oxfordjournals.aje.a114313. [DOI] [PubMed] [Google Scholar]
  18. Hosoda Y., Kosuda T., Yamamoto M., Hongo O., Mochizumi H., Mikami R., Homma H., Fujita S., Ohira I., Izumi T. A cooperative study of sarcoidosis in Asia and Africa: descriptive epidemiology. Ann N Y Acad Sci. 1976;278:347–354. doi: 10.1111/j.1749-6632.1976.tb47045.x. [DOI] [PubMed] [Google Scholar]
  19. Hosoda Y., Yamaguchi M., Hiraga Y. Global epidemiology of sarcoidosis. What story do prevalence and incidence tell us? Clin Chest Med. 1997 Dec;18(4):681–694. doi: 10.1016/s0272-5231(05)70412-3. [DOI] [PubMed] [Google Scholar]
  20. Hunninghake G. W., Gadek J. E., Kawanami O., Ferrans V. J., Crystal R. G. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol. 1979 Oct;97(1):149–206. [PMC free article] [PubMed] [Google Scholar]
  21. JAMES D. G. Course and prognosis of sarcoidosis: London. Am Rev Respir Dis. 1961 Nov;84(5):66–70. doi: 10.1164/arrd.1961.84.5P2.66. [DOI] [PubMed] [Google Scholar]
  22. Jawad A. S., Hamour A. A., Wenley W. G., Scott D. G. An outbreak of acute sarcoidosis with arthropathy in Norfolk. Br J Rheumatol. 1989 Apr;28(2):178–178. doi: 10.1093/rheumatology/28.2.178. [DOI] [PubMed] [Google Scholar]
  23. Kellner H., Späthling S., Herzer P. Ultrasound findings in Löfgren's syndrome: is ankle swelling caused by arthritis, tenosynovitis or periarthritis? J Rheumatol. 1992 Jan;19(1):38–41. [PubMed] [Google Scholar]
  24. Krause A., Goebel K. M. Class II MHC antigen (HLA-DR3) predisposes to sarcoid arthritis. J Clin Lab Immunol. 1987 Sep;24(1):25–27. [PubMed] [Google Scholar]
  25. Kremer J. M. Histologic findings in siblings with acute sarcoid arthritis: association with the B8,DR3 phenotype. J Rheumatol. 1986 Jun;13(3):593–597. [PubMed] [Google Scholar]
  26. LOFGREN S. Primary pulmonary sarcoidosis. I. Early signs and symptoms. Acta Med Scand. 1953;145(6):424–431. [PubMed] [Google Scholar]
  27. LOFGREN S. Primary pulmonary sarcoidosis. II. Clinical course and prognosis. Acta Med Scand. 1953;145(6):465–474. [PubMed] [Google Scholar]
  28. Lawrence E. C., Fox T. B., Teague R. B., Bloom K., Wilson R. K. Cigarette smoking and bronchoalveolar T cell populations in sarcoidosis. Ann N Y Acad Sci. 1986;465:657–664. doi: 10.1111/j.1749-6632.1986.tb18542.x. [DOI] [PubMed] [Google Scholar]
  29. Lenhart K., Kolek V., Bártova A. HLA antigens associated with sarcoidosis. Dis Markers. 1990 Jan-Feb;8(1):23–29. [PubMed] [Google Scholar]
  30. MYERS G. B., GOTTLIEB A. M., MATTMAN P. E., ECKLEY G. M., CHASON J. L. Joint and skeletal muscle manifestations in sarcoidosis. Am J Med. 1952 Feb;12(2):161–169. doi: 10.1016/0002-9343(52)90209-x. [DOI] [PubMed] [Google Scholar]
  31. Martinetti M., Tinelli C., Kolek V., Cuccia M., Salvaneschi L., Pasturenzi L., Semenzato G., Cipriani A., Bartova A., Luisetti M. "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med. 1995 Aug;152(2):557–564. doi: 10.1164/ajrccm.152.2.7633707. [DOI] [PubMed] [Google Scholar]
  32. Mañ J., Gómez-Vaquero C., Montero A., Salazar A., Marcoval J., Valverde J., Manresa F., Pujol R. Löfgren's syndrome revisited: a study of 186 patients. Am J Med. 1999 Sep;107(3):240–245. doi: 10.1016/s0002-9343(99)00223-5. [DOI] [PubMed] [Google Scholar]
  33. Milman N., Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis. Sarcoidosis. 1990 Sep;7(2):113–118. [PubMed] [Google Scholar]
  34. Neville E., Walker A. N., James D. G. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med. 1983 Autumn;52(208):525–533. [PubMed] [Google Scholar]
  35. Olenchock S. A., Heise E. R., Marx J. J., Jr, Mentnech M. S., Mull J. C., Spurgeon D. E., Hancock J. S., Elliott J. A., Pearson D. J., Price C. D. HLA-B8 in sarcoidosis. Ann Allergy. 1981 Sep;47(3):151–153. [PubMed] [Google Scholar]
  36. Panayeas S., Theodorakopoulos P., Bouras A., Constantopoulos S. Seasonal occurrence of sarcoidosis in Greece. Lancet. 1991 Aug 24;338(8765):510–511. doi: 10.1016/0140-6736(91)90581-9. [DOI] [PubMed] [Google Scholar]
  37. Pennec Y., Youinou P., Le Goff P., Boles J. M., Le Menn G. Comparison of the manifestations of acute sarcoid arthritis with and without erythema nodosum. Immunopathogenic significance. Scand J Rheumatol. 1982;11(1):13–16. doi: 10.3109/03009748209098106. [DOI] [PubMed] [Google Scholar]
  38. Peros-Golubicić T., Ljubić S. Cigarette smoking and sarcoidosis. Acta Med Croatica. 1995;49(4-5):187–193. [PubMed] [Google Scholar]
  39. Perruquet J. L., Harrington T. M., Davis D. E., Viozzi F. J. Sarcoid arthritis in a North American Caucasian population. J Rheumatol. 1984 Aug;11(4):521–525. [PubMed] [Google Scholar]
  40. Poukkula A., Huhti E., Lilja M., Saloheimo M. Incidence and clinical picture of sarcoidosis in a circumscribed geographical area. Br J Dis Chest. 1986 Apr;80(2):138–147. doi: 10.1016/0007-0971(86)90034-3. [DOI] [PubMed] [Google Scholar]
  41. Reynolds H. Y. Bronchoalveolar lavage. Am Rev Respir Dis. 1987 Jan;135(1):250–263. doi: 10.1164/arrd.1987.135.1.250. [DOI] [PubMed] [Google Scholar]
  42. Rybicki B. A., Major M., Popovich J., Jr, Maliarik M. J., Iannuzzi M. C. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997 Feb 1;145(3):234–241. doi: 10.1093/oxfordjournals.aje.a009096. [DOI] [PubMed] [Google Scholar]
  43. Rybicki B. A., Maliarik M. J., Major M., Popovich J., Jr, Iannuzzi M. C. Genetics of sarcoidosis. Clin Chest Med. 1997 Dec;18(4):707–717. doi: 10.1016/s0272-5231(05)70414-7. [DOI] [PubMed] [Google Scholar]
  44. SOKOLOFF L., BUNIM J. J. Clinical and pathological studies of joint involvement in sarcoidosis. N Engl J Med. 1959 Apr 23;260(17):841–847. doi: 10.1056/NEJM195904232601701. [DOI] [PubMed] [Google Scholar]
  45. Smith M. J., Turton C. W., Mitchell D. N., Turner-Warwick M., Morris L. M., Lawler S. D. Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax. 1981 Apr;36(4):296–298. doi: 10.1136/thx.36.4.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Spilberg I., Siltzbach L. E., McEwen C. The arthritis of sarcoidosis. Arthritis Rheum. 1969 Apr;12(2):126–137. doi: 10.1002/art.1780120209. [DOI] [PubMed] [Google Scholar]
  47. Terris M., Chaves A. D. An epidemiologic study of sarcoidosis. Am Rev Respir Dis. 1966 Jul;94(1):50–55. doi: 10.1164/arrd.1966.94.1.50. [DOI] [PubMed] [Google Scholar]
  48. Valeyre D., Soler P., Clerici C., Pré J., Battesti J. P., Georges R., Hance A. J. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax. 1988 Jul;43(7):516–524. doi: 10.1136/thx.43.7.516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Veale D., Fitzgerald O. Acute sarcoid arthropathy--an infective cause? Br J Rheumatol. 1990 Apr;29(2):158–159. doi: 10.1093/rheumatology/29.2.158-b. [DOI] [PubMed] [Google Scholar]
  50. Warren C. P. Extrinsic allergic alveolitis: a disease commoner in non-smokers. Thorax. 1977 Oct;32(5):567–569. doi: 10.1136/thx.32.5.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Yamaguchi E., Itoh A., Furuya K., Miyamoto H., Abe S., Kawakami Y. Release of tumor necrosis factor-alpha from human alveolar macrophages is decreased in smokers. Chest. 1993 Feb;103(2):479–483. doi: 10.1378/chest.103.2.479. [DOI] [PubMed] [Google Scholar]
  52. Yamaguchi E., Okazaki N., Itoh A., Abe S., Kawakami Y., Okuyama H. Interleukin 1 production by alveolar macrophages is decreased in smokers. Am Rev Respir Dis. 1989 Aug;140(2):397–402. doi: 10.1164/ajrccm/140.2.397. [DOI] [PubMed] [Google Scholar]
  53. van der Horst-Bruinsma I. E., Speyer I., Visser H., Breedveld F. C., Hazes J. M. Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. Br J Rheumatol. 1998 Oct;37(10):1084–1088. doi: 10.1093/rheumatology/37.10.1084. [DOI] [PubMed] [Google Scholar]
  54. van der Horst-Bruinsma I. E., Visser H., Hazes J. M., Breedveld F. C., Verduyn W., Schreuder G. M., de Vries R. R., Zanelli E. HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum Immunol. 1999 Feb;60(2):152–158. doi: 10.1016/s0198-8859(98)00101-3. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES